Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OncoCyte Corp OCX

Healthcare Biotechnology
Oncocyte Corporation is a precision diagnostics company. The Company is engaged in the development of Oncocytes tests and the acquisition of proprietary molecular technologies in the fields of oncology and transplantation. The Company’s products include DetermaIO, VitaGraft, DetermaCNI and GraftAssure. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict... see more

Recent & Breaking News (NDAQ:OCX)

Onex Credit Hires CLO Veteran Brian Horton

MarketWire Canada October 11, 2016

Onex and Baring Asia Complete Acquisition of Thomson Reuters' Intellectual Property & Science Business for $3.55 Billion

MarketWire Canada October 3, 2016

Onex Completes Investment in WireCo WorldGroup

MarketWire Canada September 30, 2016

Onex Third-Quarter Dividend Declared

MarketWire Canada September 22, 2016

OncoCyte Corporation to Present at the 2016 Aegis Growth Conference

GlobeNewswire September 20, 2016

OncoCyte to Present Initial Data on its Breast Cancer Diagnostic Test at the Prestigious San Antonio Breast Cancer Symposium

GlobeNewswire September 8, 2016

OncoCyte Corporation to Present at the Annual Gateway Conference

GlobeNewswire September 7, 2016

Don M. Bailey Appointed to OncoCyte Corporation’s Board of Directors

GlobeNewswire August 29, 2016

OncoCyte Corporation Announces the Closing of Two Private Placement Transactions Generating Gross Proceeds of $10.55 Million

GlobeNewswire August 29, 2016

OncoCyte Reports Second Quarter 2016 Financial Results

GlobeNewswire August 11, 2016

OncoCyte Commences Analytical Verification Study for Lung Cancer Diagnostic Test

GlobeNewswire August 10, 2016

BioTime, Inc. Reports Second Quarter Results and Recent Corporate Accomplishments

Business Wire August 9, 2016

OncoCyte and The Wistar Institute Announce Presentation of Lung Data at CHEST 2016 Annual Meeting

GlobeNewswire July 27, 2016

OncoCyte to Report Second Quarter Financial Results on August 11, 2016

GlobeNewswire July 21, 2016

OncoCyte Presents Positive Bladder Cancer Diagnostic Data at the 2016 American Society of Clinical Oncology Annual Meeting

GlobeNewswire June 6, 2016

OncoCyte to Release Bladder Cancer Data at the 2016 American Society of Clinical Oncology Annual Meeting

GlobeNewswire May 19, 2016

OncoCyte Reports First Quarter 2016 Financial Results

GlobeNewswire May 18, 2016

OncoCyte to Report First Quarter Financial Results on May 18, 2016

GlobeNewswire May 12, 2016

OncoCyte's Bladder Cancer Abstract to be Featured in a Poster Discussion Session at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire April 21, 2016

OncoCyte and The Wistar Institute Announce Positive Results in the Development of a Blood-based Lung Cancer Test

GlobeNewswire April 4, 2016